Patterson; Lori Jean
Patent Applications and Registrations
Patent applications and USPTO patent grants for Patterson; Lori Jean.The latest application filed is for "4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds".
Company Profile
12.43.47
- Patterson; Lori Jean - San Francisco CA
Patent Activity
| Patent | Date |
|---|---|
| 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20220087995 - Patterson; Lori Jean ; et al. | 2022-03-24 |
| Crystalline Form Of A 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compound App 20210290608 - Patterson; Lori Jean ; et al. | 2021-09-23 |
| Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound Grant 10,946,006 - Patterson , et al. March 16, 2 | 2021-03-16 |
| 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Grant 10,946,007 - Patterson , et al. March 16, 2 | 2021-03-16 |
| 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20200316048 - Patterson; Lori Jean ; et al. | 2020-10-08 |
| Crystalline Form Of A 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compound App 20200316047 - Patterson; Lori Jean ; et al. | 2020-10-08 |
| 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Grant 10,722,504 - Patterson , et al. | 2020-07-28 |
| Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound Grant 10,576,073 - Patterson , et al. | 2020-03-03 |
| 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20200000792 - Patterson; Lori Jean ; et al. | 2020-01-02 |
| 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Grant 10,441,579 - Patterson , et al. Oc | 2019-10-15 |
| Crystalline Form Of A 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compound App 20190142816 - Patterson; Lori Jean ; et al. | 2019-05-16 |
| 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20190134019 - Patterson; Lori Jean ; et al. | 2019-05-09 |
| Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound Grant 10,226,454 - Patterson , et al. | 2019-03-12 |
| 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Grant 10,206,913 - Patterson , et al. Feb | 2019-02-19 |
| 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20180289687 - Patterson; Lori Jean ; et al. | 2018-10-11 |
| 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Grant 10,034,870 - Patterson , et al. July 31, 2 | 2018-07-31 |
| Crystalline Form Of A 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compound App 20180055830 - Patterson; Lori Jean ; et al. | 2018-03-01 |
| 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20180050024 - Patterson; Lori Jean ; et al. | 2018-02-22 |
| 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Grant 9,675,599 - Patterson , et al. June 13, 2 | 2017-06-13 |
| 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20160184288 - Patterson; Lori Jean ; et al. | 2016-06-30 |
| Crystalline Form Of A 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compound App 20160022660 - Patterson; Lori Jean ; et al. | 2016-01-28 |
| 3-phenoxymethylpyrrolidine compounds Grant 9,227,933 - Stangeland , et al. January 5, 2 | 2016-01-05 |
| 4-[2-(2-fluorophenoxy methyl)phenyl]piperidine compounds Grant 9,162,982 - Patterson , et al. October 20, 2 | 2015-10-20 |
| Crystalline form of a 4-[2-(2-fluorophenoxymethyl) phenyl]piperidine compound Grant 9,073,859 - Patterson , et al. July 7, 2 | 2015-07-07 |
| 3-phenoxymethylpyrrolidine Compounds App 20150126577 - Stangeland; Eric ; et al. | 2015-05-07 |
| 1-(2-phenoxymethylphenyl)piperazine compounds Grant 9,012,460 - Stangeland , et al. April 21, 2 | 2015-04-21 |
| Serotonin reuptake inhibitors Grant 9,000,191 - Stangeland , et al. April 7, 2 | 2015-04-07 |
| 3-(phenoxyphenylmethyl)pyrrolidine compounds Grant 8,933,249 - Stangeland , et al. January 13, 2 | 2015-01-13 |
| 3-phenoxymethylpyrrolidine compounds Grant 8,853,255 - Stangeland , et al. October 7, 2 | 2014-10-07 |
| 1-(2-phenoxymethylphenyl)piperazine Compounds App 20140288089 - Stangeland; Eric L. ; et al. | 2014-09-25 |
| Serotonin Reuptake Inhibitors App 20140243536 - Stangeland; Eric L. ; et al. | 2014-08-28 |
| 1-(2-phenoxymethylphenyl)piperazine compounds Grant 8,778,949 - Stangeland , et al. July 15, 2 | 2014-07-15 |
| Serotonin reuptake inhibitors Grant 8,729,119 - Stangeland , et al. May 20, 2 | 2014-05-20 |
| 4-[2-(2-fluorophenoxy Methyl)phenyl]piperidine Compounds App 20140057944 - Patterson; Lori Jean ; et al. | 2014-02-27 |
| Crystalline Form Of A 4-[2-(2-fluorophenoxymethyl) Phenyl]piperidine Compound App 20140045892 - Patterson; Lori Jean ; et al. | 2014-02-13 |
| 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Grant 8,604,058 - Patterson , et al. December 10, 2 | 2013-12-10 |
| 1-(2-phenoxymethylheteroaryl) Piperidine And Piperazine Compounds App 20130324550 - Stangeland; Eric L. ; et al. | 2013-12-05 |
| Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound Grant 8,592,596 - Patterson , et al. November 26, 2 | 2013-11-26 |
| Serotonin Reuptake Inhibitors App 20130253013 - Stangeland; Eric L. ; et al. | 2013-09-26 |
| 3-phenoxymethylpyrrolidine Compounds App 20130237581 - Stangeland; Eric L. ; et al. | 2013-09-12 |
| 1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds Grant 8,530,663 - Stangeland , et al. September 10, 2 | 2013-09-10 |
| 3-(phenoxyphenylmethyl)pyrrolidine Compounds App 20130178509 - Stangeland; Eric ; et al. | 2013-07-11 |
| Serotonin reuptake inhibitors Grant 8,471,040 - Stangeland , et al. June 25, 2 | 2013-06-25 |
| 3-phenoxymethylpyrrolidine compounds Grant 8,455,665 - Stangeland , et al. June 4, 2 | 2013-06-04 |
| Crystalline Form Of A 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compound App 20130030185 - Patterson; Lori Jean ; et al. | 2013-01-31 |
| 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20130030020 - Patterson; Lori Jean ; et al. | 2013-01-31 |
| 3-phenoxymethylpyrrolidine Compounds App 20120309985 - STANGELAND; Eric ; et al. | 2012-12-06 |
| 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Grant 8,304,432 - Patterson , et al. November 6, 2 | 2012-11-06 |
| Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound Grant 8,304,433 - Patterson , et al. November 6, 2 | 2012-11-06 |
| 3-phenoxymethylpyrrolidine compounds Grant 8,273,786 - Stangeland , et al. September 25, 2 | 2012-09-25 |
| 3-(phenoxyphenylmethyl)pyrrolidine compounds Grant 8,242,164 - Stangeland , et al. August 14, 2 | 2012-08-14 |
| Serotonin Reuptake Inhibitors App 20120088799 - STANGELAND; Eric L. ; et al. | 2012-04-12 |
| 3-(phenoxyphenylmethyl)pyrrolidine Compounds App 20110275694 - Stangeland; Eric ; et al. | 2011-11-10 |
| 3-phenoxymethylpyrrolidine Compounds App 20110257243 - Stangeland; Eric ; et al. | 2011-10-20 |
| 1-(2-phenoxymethylheteroaryl)piperidine And Piperazine Compounds App 20110230495 - Stangeland; Eric L. ; et al. | 2011-09-22 |
| 3-phenoxymethylpyrrolidine compounds Grant 7,994,209 - Strangeland , et al. August 9, 2 | 2011-08-09 |
| 1-(2-phenoxymethylphenyl)piperazine Compounds App 20110172246 - Stangeland; Eric L. ; et al. | 2011-07-14 |
| 3-(phenoxyphenylmethyl)pyrrolidine compounds Grant 7,888,386 - Stangeland , et al. February 15, 2 | 2011-02-15 |
| 3-phenoxymethylpyrrolidine Compounds App 20110021597 - STANGELAND; Eric ; et al. | 2011-01-27 |
| 3-phenoxymethylpyrrolidine Compounds App 20110009465 - Stangeland; Eric ; et al. | 2011-01-13 |
| 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, And 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl Compounds App 20100267743 - Stangeland; Eric L. ; et al. | 2010-10-21 |
| 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds App 20100125092 - Patterson; Lori Jean ; et al. | 2010-05-20 |
| Crystalline Form Of A 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compound App 20100125093 - Patterson; Lori Jean ; et al. | 2010-05-20 |
| 3-(phenoxyphenylmethyl)pyrrolidine Compounds App 20100022616 - Stangeland; Eric ; et al. | 2010-01-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 